Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Targeting the uncommon alterations in CRC

Andrea Sartore-Bianchi, MD, ASST Great Niguarda Metropolitan Hospital, Milan, discusses targeting uncommon alterations in colorectal cancer (CRC), including HER2 amplifications, KRASG12C mutations and alterations in NTRK, ALK and RET genes. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

View our new feature exploring genomic biomarkers in metastatic colorectal cancer here: